Braveheart Bio, Inc. (NASDAQ:BRVE) Financings

Braveheart Bio, Inc.

Financings

RaiseDate
Public offering of common stock
Closed: US$439.9M in the latest tranche · US$18 a share · Goldman Sachs & Co. LLC +4
Dealers: Goldman Sachs & Co. LLC (co-lead), Jefferies (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead)
Sep 8, 2026

Read by 6ix AI from the company's releases